MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Therapeutic Proteins Inc

Therapeutic Proteins Inc
Developer / supplier of biosimilar products

The company in detail

Profile

Has a portfolio of biosimilar products.  Please contact us for a complete list or for the development of a product that you would like to commercialize.

Under development are pegylated biosimilars and monoclonal antibodies.

Partnering strategy/interests

Seeking marketing partners for: Europe, USA, Japan, and other markets.

Out-licensing

Biosimilar to Epogen®/Eprix®; available for purchase in bulk or finished product form More
Biosimilar to Neupogen®; available in bulk or finished More
Biosimilar to Avonex®; available in bulk or finished More

Contact details

Mr. Thomas L. Flynn III
Chief Executive Officer

Contact directly

Head office

Therapeutic Proteins Inc
111 Pfingsten Road
Suite 105
Deerfield
Illinois
60015
Illinois

Company figures

Formed: 2003

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us